Media-OutReach Newswire Agilis Robotics Completes Cadaver Study for a Novel Endoluminal Surgical Robot, Aims at First-in-human (FIH) Trial This Year
Media-OutReach Newswire Goldstream Investment Limited: Proposed Strategic Acquisition of Three High-quality Assets
Media-OutReach Newswire Immuno Cure’s Anti-Δ42PD1 Antibody Project Awarded HKSAR Government’s RAISe+ Scheme Funding
Media-OutReach Newswire Secarna Pharmaceuticals and Orbit Discovery enter collaboration to discover and develop peptide-conjugated targeted antisense oligonucleotide therapeutics
Media-OutReach Newswire Quality HealthCare Partners with eHealth to Enhance Patient Treatment Efficiency
Media-OutReach Newswire Merck Launches First All-in-One Genetic Stability Assay to Accelerate Biosafety Testing
Media-OutReach Newswire GC secures the Top 1% in S&P Global ESG Scores and is ranked as the No. 1 Sustainable Company out of 355 Chemical Companies Worldwide
Media-OutReach Newswire Berlin Cures' BC 007 Targeting Long COVID Achieves Solid Progress with Over 50% Patient Recruitment in Phase II Trial
Media-OutReach Newswire Berlin Cures' BC 007 Targets Long COVID: Solid Phase II Trial Progress with Over 50% Patient Recruitment
Media-OutReach Newswire VinBrain and Global Fund continue joining forces to tackle Vietnam's tuberculosis challenge through AI in 2024